| Citation: |
CHEN Bai-sheng, LI Ping, ZHOU Ying, et al. The role of promyelocytic leukemia protein in the carcinogenesis of colorectal adenoma[J]. Chin J Clin Med, 2022, 29(1): 23-29. DOI: 10.12025/j.issn.1008-6358.2022.20211765
|
To analyze expression of promyelocytic leukemia protein (PML) in colorectal adenoma, colorectal cancer tissues, and colorectal cancer cells, and to explore the role of PML in the occurrence and development of colorectal cancer.
The expression level of PML in colorectal cancer, colorectal adenoma, and normal colorectal mucosa were detected by immunohistochemistry and Western blotting. The expression of PML in 10 different colorectal cancer cell lines were detected, and suitable cell lines were screened for further cell migration, and invasion tests. Furthermore, PML silenced and overexpressed colorectal cancer cell models were established, and cell migration, invasion, proliferation, and apoptosis experiments were performed. The effects of PML on vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) expressions were analyzed.
Compared with normal tissue, the expression of PML decreased in adenoma tissue and further decreased in colorectal cancer tissue (P < 0.05). Among the 10 different colorectal cancer cell lines, the cells with lower PML expression were more invasive. After silencing PML, the migration, invasion, and proliferation rates of colorectal cancer cells increased, and apoptosis decreased (P < 0.05); while the migration, invasion, and proliferation rates of colorectal cancer cells decreased with high expression of PML, and apoptosis increased (P < 0.05). After silencing PML, the expressions of EGFR and VEGF in colorectal cancer cells were significantly increased (P < 0.05); while the expressions of EGFR and VEGF in colorectal cancer cells decreased significantly with high PML expression (P < 0.05).
PML is lowly expressed in colorectal adenoma tissue, and its expression is further reduced in colorectal cancer tissue. PML can inhibit the migration, invasion, and proliferation of colorectal cancer cells, and promote their apoptosis, through the negative regulation of VEGF and EGFR.
| [1] |
胡煦晨, 杨雪松, 刘艳霞, 等. 结直肠腺瘤382例癌变相关危险因素分析[J]. 中华消化杂志, 2016, 36(4): 271-274. DOI: 10.3760/cma.j.issn.0254-1432.2016.04.014
HU X C, YANG X S, LIU Y X, et al. Analysis of risk factors related to carcinogenesis in 382 cases of colorectal adenoma[J]. Chinese Journal of Digestion, 2016, 36(4): 271-274. DOI: 10.3760/cma.j.issn.0254-1432.2016.04.014
|
| [2] |
SALOMONI P, FERGUSON B J, WYLLIE A H, et al. New insights into the role of PML in tumour suppression[J]. Cell Res, 2008, 18(6): 622-640. DOI: 10.1038/cr.2008.58
|
| [3] |
GURRIERI C, CAPODIECI P, BERNARDI R, et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins[J]. J Natl Cancer Inst, 2004, 96(4): 269-279. DOI: 10.1093/jnci/djh043
|
| [4] |
林生力, 陈艺樟, 易拓, 等. 早幼粒细胞白血病蛋白的缺失对胃癌和结直肠癌预后的影响[J]. 中国临床医学, 2015, 22(5): 637-642. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX201505017.htm
LIN S L, CHEN Y Z, YI T, et al. Effect of promyelocytic leukemia protein deficiency on prognosis of gastric and colorectal cancers[J]. Chinese Journal of Clinical Medicine, 2015, 22(5): 637-642. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX201505017.htm
|
| [5] |
PAPAMICHALIS P A, ZACHOU K, PAPAMICHALI R A, et al. Promyelocytic leukemia antigen expression: a histological marker for primary biliary cholangitis diagnosis?[J]. J Transl Int Med, 2021, 9(1): 43-51. DOI: 10.2478/jtim-2021-0008
|
| [6] |
HSU K S, KAO H Y. PML: Regulation and multifaceted function beyond tumor suppression[J]. Cell Biosci, 2018, 8: 5. DOI: 10.1186/s13578-018-0204-8
|
| [7] |
COLLIN V, GRAVEL A, KAUFER B B, et al. The promyelocytic leukemia protein facilitates human herpesvirus 6B chromosomal integration, immediate-early 1 protein multiSUMOylation and its localization at telomeres[J]. PLoS Pathog, 2020, 16(7): e1008683. DOI: 10.1371/journal.ppat.1008683
|
| [8] |
FRUEHAUF J. EGFR function and detection in cancer therapy[J]. J Exp Ther Oncol, 2006, 5(3): 231-246. DOI: 10.1002/chin.200645277/abstract
|
| [9] |
KOCH S, CLAESSON-WELSH L. Signal transduction by vascular endothelial growth factor receptors[J]. Cold Spring Harb Perspect Med, 2012, 2(7): a006502.
|
| [10] |
BERNARDI R, PAPA A, EGIA A, et al. PML represses tumour progression through inhibition of mTOR[J]. EMBO Mol Med, 2011, 3(5): 249-257. DOI: 10.1002/emmm.201100130
|
| [11] |
BERNARDI R, GUERNAH I, JIN D, et al. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR[J]. Nature, 2006, 442(7104): 779-785. DOI: 10.1038/nature05029
|
DownLoad: